Month: March 2023
By Leveraging AWS Marketplace’s Reach and with SoftwareONE’s help, Aware Will Further Expand Access to World Class Biometric Authentication Capabilities for Enterprise Customers Globally
BURLINGTON, Mass., March 28, 2023 (GLOBE NEWSWIRE) — A vast majority of enterprises worldwide use cloud computing or applications based in the cloud, and this number is only set to grow in the coming years. In this context, AWS Marketplace is transforming how enterprises find, subscribe to and deploy third-party software, with decision-makers reporting feeling 2.4 times better about purchasing through AWS Marketplace compared to other sources. To tap this vast market reach and trust level, Aware, Inc. (NASDAQ: AWRE) announced it is working with SoftwareONE and AWS to prepare AwareID® for availability on AWS Marketplace.
“AwareID will be one...
Savosolar Plc – Managers’ Transaction, Eero Auranne, March 2023
Written by Customer Service on . Posted in Public Companies.
Savosolar Plc Company Announcement 28 March 2023 at 3.00 p.m. (CEST)Savosolar Plc – Managers’ Transaction, Eero Auranne, March 2023
Person subject to the notification requirementName:
Auranne, Eero
Position:
Member of the Board/Deputy member
Initial Notification
Reference number:
28036/5/4
IssuerName:
Savosolar OyjLEI:
743700J1YZ8IEJAPDL21
Transaction detailsTransaction date:
2023-03-27Venue:
FIRST NORTH GROWTH MARKET FINLAND (FSME)
Nature of the transaction:
Subscription Instrument:
ShareISIN:
FI4000425848 Volume:
6428Unit price:
0.05400 Euro Aggregated transactionsVolume:
6428Volume weighted average price:
0.05400 EuroSAVOSOLAR PLC
For more information:
Savosolar Plc Managing Director Jari Varjotie Phone: +358 400 419 734...
Distoken Acquisition Corporation Announces Upcoming Automatic Unit Separation, Commencing March 30, 2023
Written by Customer Service on . Posted in Mergers And Acquisitions.
New York, NY, March 28, 2023 (GLOBE NEWSWIRE) — Distoken Acquisition Corporation (NASDAQ: DISTU) (the “Company”) announced today that, commencing March 30, 2023, the Company’s units will no longer trade, and that the Company’s ordinary shares, rights and warrants, which together comprise the units sold in the Company’s initial public offering, will commence trading separately. The ordinary shares, rights and warrants that are separated will trade on the Nasdaq Global Market under the symbols “DIST,” “DISTR,” and “DISTW,” respectively. This is a mandatory and automatic separation, and no action is required by the holders of units.
The units were initially offered by the Company in an underwritten offering. I-Bankers Securities, Inc. and IB Capital LLC acted as the joint book-runners for the offering. The offering was made only...
Acrivon Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
WATERTOWN, Mass., March 28, 2023 (GLOBE NEWSWIRE) — Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biopharmaceutical company developing precision oncology medicines that it matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proprietary proteomics-based patient responder identification platform, today reported financial results for the fourth quarter and full year ended December 31, 2022 and reviewed business highlights.
“The mission of Acrivon is to pioneer a new era of precision oncology, and 2022 was an important year for us,” said Peter Blume-Jensen, M.D., Ph.D., chief executive officer, president, and founder of Acrivon. “Amongst our many achievements, we are particularly excited about our successful IPO on NASDAQ and the...
RocketLinks participates in the international development of the Dékuple Group by expanding into the UK and US markets
Written by Customer Service on . Posted in Public Companies.
Bertrand-Laurioz Dékuple CEO
Bertrand-Laurioz Dékuple CEOMaxime Doki-Thonon Founder and CEO RocketLinks
Maxime Doki-Thonon Founder and CEO RocketLinksRocketLinks participates in the international development of the Dékuple Group by expanding into the UK and US markets
Paris, March 28, 2023 – RocketLinks, the Dékuple Group’s SaaS martech solution, continues its international development by expanding its market to the UK and the USA and is part of the Group’s overall internationalization process.
With 10% of its revenue to be generated internationally by 2022, RocketLinks, a sponsored article buying platform that offers a full range of services for SEO and branding performance, has been preparing this expansion phase to international markets for several months:Recruitment of a business developer and a lead media...
Azincourt Energy Completes the 2023 Drill Program at the East Preston Uranium Project, Athabasca Basin, Saskatchewan
Written by Customer Service on . Posted in Public Companies.
Vancouver, BC, March 28, 2023 (GLOBE NEWSWIRE) — Skyharbour Resources Ltd.’s (TSX-V:SYH) (OTCQX:SYHBF) (Frankfurt:SC1P) (the “Company”) partner company Azincourt Energy (“Azincourt”) is pleased to announce that the 2023 exploration program has been completed at the East Preston uranium project in the Athabasca Basin, Saskatchewan, Canada.
Project Location – Western Athabasca Basin, Saskatchewan, Canada:https://www.skyharbourltd.com/_resources/maps/Sky_EastPreston_20211209.jpg
Drilling for the 2023 program at the East Preston Project commenced on February 2nd and was recently completed. In total 3,066 metres has been completed in 13 drill holes. After some initial startup delays due to extreme weather variations, two drill rigs were able to complete 12 drill holes and one abandoned due to drilling difficulties. Drilling was focused...
Compass Therapeutics to Participate in the Cantor Fitzgerald Future of Oncology Symposium
Written by Customer Service on . Posted in Public Companies.
BOSTON, March 28, 2023 (GLOBE NEWSWIRE) — Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in the Cantor Fitzgerald Future of Oncology Symposium, which is taking place virtually on April 3 – 5, 2023.
Presentation details:
Date: Tuesday, April 4 Time: 8:15 AM ET
About Compass TherapeuticsCompass Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. Compass’s scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. Compass’s pipeline of novel product candidates is designed to target multiple...
Smart for Life’s Greens First CEO Ryan Benson Provides Video Update on Boxout Distribution Agreement
Written by Customer Service on . Posted in Public Companies.
Video Details Transaction and Value of Agreement
MIAMI, March 28, 2023 (GLOBE NEWSWIRE) — Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a global leader in the Health & Wellness sector marketing and manufacturing nutritional supplements and foods worldwide, today provided a video presentation of Ryan Benson, Greens First CEO, discussing the recently announced Boxout distribution agreement.
Darren Minton, Chief Executive Officer of Smart for Life, noted, “The recently announced Boxout agreement entered into by Smart for Life’s Greens First subsidiary is a material event for us and a major component driving the growth of that company. Ryan Benson, Greens First CEO and a key member of our management team, engineered that transaction and the video presented here details the Boxout and Greens First partnership.”
Interested...
Adeia Signs Long-Term Semiconductor Patent License Agreement with Western Digital
Written by Customer Service on . Posted in Public Companies.
Agreement includes a license to Adeia’s Hybrid Bonding Portfolio
SAN JOSE, Calif., March 28, 2023 (GLOBE NEWSWIRE) — Adeia Inc. (Nasdaq: ADEA) (“Adeia” or the “Company”), the company whose patented innovations enhance billions of devices, today announced that Western Digital (Nasdaq: WDC), a global leader in data storage solutions, entered into a long-term agreement to license Adeia’s semiconductor patent portfolio, including those relating to hybrid bonding.
“Western Digital continues to be a leader in the industries it serves with next-generation 3D NAND memory and storage solutions,” said Dana Escobar, chief licensing officer and general manager, semiconductor, at Adeia. “This agreement demonstrates the long-term value proposition offered by Adeia’s intellectual property portfolio to this vital sector...
Adeia Signs Long-Term Semiconductor Patent License Agreement with Kioxia
Written by Customer Service on . Posted in Public Companies.
Agreement includes a license to Adeia’s Hybrid Bonding Portfolio
SAN JOSE, Calif., March 28, 2023 (GLOBE NEWSWIRE) — Adeia Inc. (Nasdaq: ADEA) (“Adeia” or the “Company”), the company whose patented innovations enhance billions of devices, today announced that Kioxia Corporation, a world leader in flash memory and solid-state drives, entered into a long-term agreement to license Adeia’s semiconductor patent portfolio, including those relating to hybrid bonding.
“Kioxia continues to be a leader in the industries it serves with next-generation 3D NAND memory and storage solutions,” said Dana Escobar, chief licensing officer and general manager, semiconductor, at Adeia. “This agreement demonstrates the long-term value proposition offered by Adeia’s intellectual property portfolio to this vital sector of the...
